Reduction of pulmonary edema by short-acting local anesthetics

Reg Anesth Pain Med. 2006 May-Jun;31(3):254-9. doi: 10.1016/j.rapm.2006.01.003.

Abstract

Background and objectives: Local anesthetics (LAs) possess a variety of effects that cannot be explained by the typical block of neuronal sodium channels. Antithrombotic effects of LAs are well known, but LAs also act as bactericides. Therefore, an investigation of the influence of LAs on the inflammatory response of the isolated rat lung (n = 78) to an N-formyl-l-leucin-methionyl-l-phenylalanine (FMLP) stimulus was performed.

Methods: The experiments were performed on isolated and ventilated rat lungs perfused with cell-free and plasma-free buffer. LAs (lidocaine and mepivacaine) were injected in various concentrations before application and activation of human granulocytes by FMLP. Pulmonary arterial pressure (PAP) and lung weight gain were monitored continuously. LAs in final dosages from 10(-2) to 10(-7) mg/kg body weight (n = 6 each) were injected into the pulmonary artery before treatment with FMLP (10(-6) M) to induce pulmonary arterial hypertension. Perfusate samples were taken intermittently to determine thromboxane A(2) (TX A(2)) and endothelin-1 concentrations. Microscopic analyses were performed to assess the degree of lung injury.

Results: Pretreatment with LAs significantly reduced the FMLP-induced PAP increase (treatment group v sham group: 0.5 to 5 mm Hg v 8 mm Hg; P < .05) and the release of endothelin-1 (2.4 v 5 fmol/mL). Histologic damage seen as acute granulocytic alveolitis was reduced by lidocaine and mepivacaine, even below clinically relevant concentrations.

Conclusion: LA pretreatment reduces inflammatory reactions after FMLP stimulus.

Publication types

  • Comparative Study

MeSH terms

  • Anesthetics, Local / pharmacology*
  • Anesthetics, Local / therapeutic use
  • Animals
  • Blood Pressure
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Granulocytes / drug effects
  • Granulocytes / pathology
  • In Vitro Techniques
  • Lidocaine / pharmacology
  • Lidocaine / therapeutic use
  • Lung / blood supply
  • Lung / drug effects*
  • Lung / pathology
  • Mepivacaine / pharmacology
  • Mepivacaine / therapeutic use
  • N-Formylmethionine Leucyl-Phenylalanine
  • Organ Size
  • Pneumonia / chemically induced
  • Pneumonia / drug therapy
  • Pneumonia / pathology
  • Pulmonary Artery / drug effects*
  • Pulmonary Artery / physiopathology
  • Pulmonary Edema / chemically induced
  • Pulmonary Edema / drug therapy*
  • Pulmonary Edema / pathology
  • Rats
  • Rats, Sprague-Dawley
  • Time Factors

Substances

  • Anesthetics, Local
  • N-Formylmethionine Leucyl-Phenylalanine
  • Lidocaine
  • Mepivacaine